ArticleOrphanet journal of rare diseases2021

Long-term safety and effectiveness of velaglucerase alfa in Gaucher disease: 6-year interim analysis of a post-marketing surveillance in Japan.

Rieko Sagara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.